Progress towards global standardization for quantitative flow cytometry
Bioanalysis
.
2021 Nov;13(21):1591-1595.
doi: 10.4155/bio-2021-0148.
Epub 2021 Sep 16.
Authors
Christèle Gonneau
1
,
Lili Wang
2
,
Shibani Mitra-Kaushik
3
,
Paul C Trampont
4
,
Virginia Litwin
5
Affiliations
1
Central Laboratory Services, Labcorp Drug Development, 1217 Meyrin, Geneva, Switzerland.
2
Biosystems & Biomaterials Division, National Institute of Standards & Technology (NIST), Gaithersburg, MD 20899, USA.
3
Bioanalytics-Genomic Medicine Unit, Sanofi, Framingham, MA 01701, USA.
4
Nexelis, Seattle, WA 98119, USA (currently at Moderna Inc., Norwood, MA 02062, USA).
5
Caprion Biosciences, QC, H2X 3Y7, Canada.
PMID:
34528829
DOI:
10.4155/bio-2021-0148
No abstract available
Keywords:
CLSI H62; NIST consortium; cell and gene therapy; flow cytometry; standards; validation.
Publication types
Editorial
MeSH terms
Flow Cytometry / standards*
Humans
Reference Standards